H U Group Holdings Inc 4544

Morningstar Rating
¥4,026.00 −8.00 (0.20%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

4544 is trading at a LOCK|#Y?Vr premium.
Price
¥4,034.00
Fair Value
LOCK|>>.L>$&RLjC
Uncertainty
LOCK|%$y?
1-Star Price
LOCK|Vv.YrmWMQ#
5-Star Price
LOCK|x#.k&#$^S
Economic Moat
LOCK|W?%
Capital Allocation
—

Trading Information

Previous Close Price
¥4,034.00
Day Range
¥3,985.00–4,050.00
52-Week Range
¥2,944.50–4,073.00
Bid/Ask
¥4,024.00 / ¥4,045.00
Shares Outstanding
54.15M
Market Cap
¥217.99B
Volume/Avg
135,800 / 209,832

Key Statistics

Price/Earnings (Normalized)
41.20
Price/Sales
0.89
Dividend Yield (Trailing)
3.10%
Dividend Yield (Forward)
3.10%
Dividend Payment Schedule
May, Dec
Total Yield
5.40%

Company Profile

H U Group Holdings Inc is engaged in the contract clinical testing, manufacturing, and sales of clinical diagnostic reagents, and sterilization and surgical-related businesses. Its reportable segments are the Inspection and related services business, the Clinical diagnostic reagent business, and the Healthcare-related services business. It generates the majority of its revenue from the Inspection and related services business segment, which provides comprehensive testing services to medical institutions.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
10,235

Valuation

Metric
4544
Price/Earnings (Normalized)
41.20
Price/Book Value
1.66
Price/Sales
0.89
Price/Cash Flow
9.27
Price/Earnings
4544

Financial Strength

Metric
4544
Quick Ratio
1.27
Current Ratio
1.76
Interest Coverage
20.37
Quick Ratio
4544

Profitability

Metric
4544
Return on Assets (Normalized)
2.65%
Return on Equity (Normalized)
5.25%
Return on Invested Capital (Normalized)
3.55%
Return on Assets
4544

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|>yBgKkWvLOCK|MhJ$255B
Danaher Corp
DHR
LOCK|d$Yz?G^LOCK|gs$160B
IDEXX Laboratories Inc
IDXX
LOCK|!mkYGW>LOCK|D$&$54B
Agilent Technologies Inc
A
LOCK|hYNh?jvLOCK|?f$49B
Waters Corp
WAT
LOCK|C^#v?g?LOCK|&^$45B
IQVIA Holdings Inc
IQV
LOCK|>JyK^<LOCK|v@xz$41B
Mettler-Toledo International Inc
MTD
LOCK|^z&XgZwlLOCK|KlyB@$34B
Illumina Inc
ILMN
LOCK|sBl^khNLOCK|p>X?!$30B
Labcorp Holdings Inc
LH
LOCK|wJPN%tYLOCK|zm^%$30B
Quest Diagnostics Inc
DGX
LOCK|Y>L<?q&LOCK|Xc?w$29B

Sponsor Center